Recombinant Human GCLM Protein: Function & Research Use

Recombinant Human GCLM Protein is the regulatory modifier subunit of glutamate-cysteine ligase (GCL), the rate-limiting enzyme in de novo glutathione biosynthesis, and serves as an essential research tool for studying antioxidant defense mechanisms, oxidative stress pathways, and cellular redox homeostasis.

Protein Name

Glutamate-Cysteine Ligase Modifier Subunit (GCLM)

Also Known As

GCS Light Chain; Gamma-ECS Regulatory Subunit; GLCLR

Biological Role

Regulatory subunit of GCL; enhances catalytic activity of GCLC and increases GSH synthesis capacity

Key Pathway

Glutathione biosynthesis; Nrf2-mediated oxidative stress response

Species

Human (Homo sapiens)

Research Applications

Oxidative stress studies, enzyme activity assays, protein interaction studies, drug target validation

SKU

rp370646

What Is GCLM? Biological Background

Glutamate-cysteine ligase (GCL) catalyzes the first and rate-limiting step in the biosynthesis of glutathione (GSH), one of the most abundant intracellular antioxidants in mammalian cells. GCL is a heterodimeric enzyme composed of two subunits: the catalytic subunit (GCLC) and the modifier (regulatory) subunit (GCLM). GCLM, encoded by the GCLM gene on chromosome 1p22.1 in humans, has no catalytic activity on its own but plays a critical regulatory role.

When GCLM associates with GCLC to form the GCL holoenzyme, it significantly lowers the K_m for glutamate, raises the K_i for GSH-mediated feedback inhibition, and increases the overall V_max of the reaction. The net result is a dramatic increase in the efficiency of GSH synthesis. This regulatory mechanism allows cells to rapidly upregulate GSH production in response to oxidative insults, electrophilic stress, or toxicological challenges.

GCLM expression is tightly regulated at the transcriptional level by the Nrf2 (Nuclear factor erythroid 2-related factor 2) / Keap1 signaling axis. Under basal conditions, Nrf2 is sequestered and degraded. Upon oxidative or electrophilic stress, Nrf2 translocates to the nucleus, binds antioxidant response elements (ARE) in the GCLM promoter, and drives transcriptional upregulation of GCLM, thereby boosting GSH synthetic capacity.

Recombinant Human GCLM Protein: Product Overview

Recombinant Human GCLM Protein (SKU: rp370646) is produced recombinantly to support in vitro biochemical and cell biology research. Recombinant expression systems allow researchers to obtain purified GCLM protein in quantities and purity levels suitable for enzymatic assays, binding studies, structural investigations, and antibody validation.

Recombinant GCLM is commonly used to reconstitute GCL holoenzyme activity in vitro by combining it with recombinant GCLC. This reconstituted system is a valuable tool for dissecting the kinetics of glutathione biosynthesis, screening small-molecule modulators of GCL activity, and studying the impact of disease-associated mutations in either subunit.

Researchers should consult the product datasheet for specific information regarding expression host, tag, purity grade, formulation buffer, and recommended storage conditions for SKU rp370646, as these parameters directly affect downstream application performance.

Research Applications of Recombinant Human GCLM Protein

Enzyme Reconstitution and Kinetic Analysis: Recombinant GCLM can be combined with recombinant GCLC to form functional GCL holoenzyme in vitro. This allows precise kinetic characterization of the enzyme complex, including determination of K_m, V_max, and inhibition constants, under defined conditions.

Drug Discovery and Target Validation: GCL is a validated therapeutic target in cancer, where GSH overproduction contributes to chemotherapy resistance. Recombinant GCLM protein supports high-throughput screening (HTS) and structure-activity relationship (SAR) studies of candidate GCL inhibitors or activators.

Protein-Protein Interaction Studies: The GCLM–GCLC interaction interface is of pharmacological interest. Recombinant GCLM can be used in pull-down assays, surface plasmon resonance (SPR), biolayer interferometry (BLI), and co-immunoprecipitation experiments to map and characterize this interaction.

Oxidative Stress Pathway Research: GCLM is a sentinel marker of cellular antioxidant capacity. Recombinant protein can serve as a positive control or calibration standard in ELISA, Western blot, and mass spectrometry-based proteomics workflows.

Antibody Validation: Purified recombinant GCLM protein is the gold standard for confirming anti-GCLM antibody specificity in Western blotting, immunofluorescence, and immunoprecipitation assays.

Handling, Storage, and Reconstitution Guidelines

To maintain the activity and integrity of Recombinant Human GCLM Protein, adhere to the following general best practices. Always consult the specific product datasheet (SKU: rp370646) for formulation-specific instructions, as conditions may vary by lot.

• Storage: Recombinant proteins are typically stored at –20 °C or –80 °C. Avoid repeated freeze-thaw cycles, which can cause protein aggregation and loss of activity. Aliquot upon first thaw.
• Reconstitution: If supplied lyophilized, reconstitute in the buffer recommended in the datasheet (commonly sterile PBS or a low-salt HEPES buffer with a carrier protein such as BSA). Allow the vial to equilibrate to room temperature before opening.
• Working Concentrations: Optimize protein concentration empirically for each assay type. Include appropriate positive and negative controls in all experiments.
• Contamination Prevention: Use sterile, nuclease-free, low-protein-binding tubes and pipette tips. Wear appropriate PPE and follow standard laboratory safety protocols.

For questions regarding product-specific formulation, activity, or compatibility, contact Aladdin Scientific technical support.

GCLM in Disease and Translational Research

Dysregulation of GCLM expression has been associated with a range of pathological conditions, making it a subject of active translational research.

Cancer: Elevated GCLM expression is observed in multiple cancer types and correlates with increased intracellular GSH levels, which can confer resistance to platinum-based chemotherapeutics and other reactive oxygen species (ROS)-inducing agents. Inhibition of GCL, including disruption of the GCLC–GCLM interaction, has been explored as a strategy to sensitize tumor cells to oxidative chemotherapy.

Neurodegenerative Disease: GSH depletion is a hallmark of neuronal oxidative stress in conditions such as Parkinson's disease and Alzheimer's disease. GCLM expression levels and polymorphisms have been investigated in connection with neuronal vulnerability to oxidative damage.

Cardiovascular Disease: Oxidative stress plays a central role in atherosclerosis, ischemia-reperfusion injury, and heart failure. GCLM upregulation is part of the cardioprotective Nrf2 response, and recombinant GCLM protein supports mechanistic studies in these contexts.

Toxicology: GCLM induction serves as a sensitive biomarker of electrophilic and oxidative stress in toxicological studies, relevant to drug safety assessment and environmental chemical risk evaluation.

Frequently asked questions

What is the difference between GCLM and GCLC?

GCLC is the catalytic subunit of glutamate-cysteine ligase and carries the active site responsible for adenylate formation and peptide bond catalysis. GCLM is the regulatory (modifier) subunit that lacks intrinsic catalytic activity but, upon association with GCLC, markedly enhances the enzyme's kinetic efficiency by lowering substrate Km and relieving GSH feedback inhibition. Both subunits are required for maximal GCL activity in vivo.

How should I store Recombinant Human GCLM Protein to preserve its activity?

Recombinant Human GCLM Protein should generally be stored at –20 °C or –80 °C, depending on the formulation specified in the product datasheet for SKU rp370646. Repeated freeze-thaw cycles should be strictly avoided; it is best practice to prepare single-use aliquots upon first thaw. Always follow the lot-specific datasheet instructions for buffer composition, carrier protein requirements, and recommended working concentrations.

Can Recombinant Human GCLM Protein be used to validate anti-GCLM antibodies?

Yes. Purified recombinant GCLM protein is ideal for confirming antibody specificity. It can be used as a positive control in Western blotting to verify band size and specificity, as a blocking antigen in competition assays, and as a coating antigen in ELISA-based antibody titer determinations. Ensure that the recombinant protein construct (full-length vs. truncated, tagged vs. untagged) matches the epitope recognized by the antibody under evaluation.

Is GCLM a suitable drug target for cancer therapy?

GCLM has attracted interest as a drug target because elevated GSH in cancer cells contributes to chemotherapy resistance. Disrupting the GCLC–GCLM protein-protein interaction or inhibiting GCL holoenzyme activity could deplete intracellular GSH, thereby sensitizing cancer cells to oxidative stress-inducing therapies. Recombinant GCLM protein supports in vitro screening and mechanistic validation of such approaches, though clinical translation remains an active area of investigation.

References

1. Griffith OW. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med. 1999;27(9-10):922-935. doi:10.1016/S0891-5849(99)00176-8
2. Lu SC. Glutathione synthesis. Biochim Biophys Acta. 2013;1830(5):3143-3153. doi:10.1016/j.bbagen.2012.09.008
3. Dickinson DA, Forman HJ. Cellular glutathione and thiols metabolism. Biochem Pharmacol. 2002;64(5-6):1019-1026. doi:10.1016/S0006-2952(02)01172-3
4. Copple IM. The Nrf2-Keap1 defence pathway: role in protection against drug-induced toxicity. Toxicology. 2012;278(3):229-236. doi:10.1016/j.tox.2010.11.016

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.